Search Within

Raymond L Comenzo

  1. "Bone Marrow Transplant"
Formats
  1. Meeting Abstract (13)
  2. Journal Article (3)
  3. Book Section (2)
Groups
  1. Bone Marrow Transplant (18)
  2. Center for Hematologic Malignancies (18)
  3. Department of Medicine (18)
  4. Hematologic Malignancies, Division of (18)
  5. Survivorship Research (11)
  6. Myeloma (8)

More Groups

People
  1. Heather Landau (11)
  2. Ping Zhou (9)
  3. Stephen Nimer (9)
  4. Adam Boruchov (8)
  5. Hani Hassoun (8)
  6. Adam Cohen (7)

More People

Years
  1. 2012 (1)
  2. 2010 (1)
  3. 2009 (2)
  4. 2008 (7)
  5. 2007 (2)
  6. 2006 (3)

More Years

Publications
  1. Blood (9)
  2. Amyloid (2)
  3. Journal of Clinical Oncology (2)
  4. XIth International Symposium on Amyloidosis (2)
  5. British Journal of Haematology (1)
  6. Haematologica (1)

More Publications

Publishers
  1. American Society of Hematology (9)
  2. American Society of Clinical Oncology (2)
  3. CRC Press/Taylor & Francis Group (2)
  4. Taylor & Francis Group (2)
  5. Ferrata Storti Foundation (1)
  6. John Wiley & Sons (1)

More Publishers

Results (18)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Risk-adapted melphalan and stem cell transplant for systemic light chain amyloidosis: A single institution experience
    Meeting Abstract

    Landau, H.; Fein, D. E.; Hassoun, H.; Bello, C.; Chou, J. F.; Devlin, S.; Giralt, S.; Comenzo, R. L.
    Blood (2012)

    Fulltext@MSK | Save
  • Conflicts of interest, authorship, and disclosures in industry-related scientific publications
    Journal Article

    Fonseca, R.; Richardson, P.; Giralt, S.; Lonial, S.; Rajkumar, S. V.; Stewart, A. K.; Bensinger, W.; Somlo, G.; Vescio, R.; Mikhael, J.; more...
    Mayo Clinic Proceedings (2010)

    Fulltext@MSK | Save
  • FDG PET/CT (FDG PET) in evaluation of response in patients with multiple myeloma (MM) treated with bortezomib, pegylated liposomal doxorubicin, and dexamethasone
    Meeting Abstract

    Pandit-Taskar, N.; Comenzo, R. L.; Hassoun, H.; Hoover, E.; Borkar, S.; Reidel, E.; Cohen, A.; Surti, C.; Nimer, S. D.; Landau, H. J.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Adjuvant bortezomib and dexamethasone following risk-adapted melphalan and stem cell transplant in patients with light-chain amyloidosis (AL)
    Meeting Abstract

    Landau, H. J.; Hoffman, J.; Hassoun, H.; Elizabeth, H.; Riedel, E.; Nimer, S. D.; Cohen, A.; Comenzo, R. L.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • The inhibitory Fcy-receptor IIB (CD32B) is highly expressed on clonal plasma cells from patients with systemic light-chain (AL) amyloidosis and provides a target for monoclonal antibody therapy
    Book Section

    Zhou, P.; Olshen, A. B.; Bonvini, E.; Koenig, S.; Fleisher, M.; Young, J.; Boruchov, A.; Comenzo, R. L.
    In Skinner, M.; Berk, J. L.; Connors, L. H.; Seldin, D. C. (Eds.) XIth International Symposium on Amyloidosis (2008)

    Fulltext@MSK | Save
  • Al amyloidosis in a patient with a T60A TTR mutation
    Book Section

    Landau, H. J.; Comenzo, R. L.; Zhou, P.; Clark, B.; Teruya-Feldstein, J.; Wang, S.; Murphy, C. L.; Solomon, A.
    In Skinner, M.; Berk, J. L.; Connors, L. H.; Seldin, D. C. (Eds.) XIth International Symposium on Amyloidosis (2008)

    Fulltext@MSK | Save
  • CD32B expression reflects phenotypic and functional heterogeneity in multiple myeloma (MM)
    Meeting Abstract

    Zhou, P.; Boruchov, A. M.; Hoffman, J. E.; Mo, Q. X.; Olshen, A.; Glasner, E.; Bonvini, E.; Koenig, S.; Drieghe, E.; Fleisher, M.; more...
    Blood (2008)

    Fulltext@MSK | Save
  • Sequential administration of bortezomib, liposomal doxorubicin and dexamethasone (BDD) followed by thalidomide and dexamethasone (TD) results in rapid control of untreated high-risk multiple myeloma (MM) and improves depth of response
    Meeting Abstract

    Landau, H.; Hassoun, H.; Cohen, A.; Hoover, E.; Kewalramani, T.; Boruchov, A.; Klimek, V.; Reich, L.; Riedel, E.; Pandit-Taskar, N.; more...
    Blood (2008)

    Fulltext@MSK | Save
  • Early adjuvant treatment after risk-adapted autologous stem cell transplant for systemic light-chain amyloidosis: Increased hospitalizations and impaired immune recovery but improved responses and overall survival
    Meeting Abstract

    Hoffman, J. E.; Hassoun, H.; Landau, H.; Hoover, E.; Cohen, A.; Nimer, S.; Comenzo, R.
    Blood (2008)

    Fulltext@MSK | Save
  • CD32B is highly expressed on clonal plasma cells from patients with systemic light-chain amyloidosis and provides a target for monoclonal antibody-based therapy
    Journal Article

    Zhou, P.; Comenzo, R. L.; Olshen, A. B.; Bonvini, E.; Koenig, S.; Maslak, P. G.; Fleisher, M.; Hoffman, J.; Jhanwar, S.; Young, J. W.; more...
    Blood (2008)

    Fulltext@MSK | Save